What's new

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised

May 16, 2025 - 14:50
 0
Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

Summary of opinion: NexGard Combo, 15/05/2025 Positive

Next Article

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, ...

Related Posts

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

EMEA-003170-PIP01-21-M02

EMEA-003170-PIP01-21-M02

May 14, 2025  0

Opinions and letters of support on the qualification of novel methodologies for medicine development

Opinions and letters of support on the qualification of...

May 8, 2025  0